• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰医护人员中疫苗接种前严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清阳性率较低:一项前瞻性队列研究。

Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study.

作者信息

Tähtinen Paula A, Ivaska Lauri, Jalkanen Pinja, Kakkola Laura, Kainulainen Leena, Hytönen Jukka, Vuorinen Tytti, Waris Matti, Peltola Ville, Oksi Jarmo, Julkunen Ilkka, Lempainen Johanna

机构信息

Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Infections and Immunity Unit, Institute of Biomedicine, University of Turku, Turku, Finland.

出版信息

Infect Dis (Lond). 2022 Jun;54(6):448-454. doi: 10.1080/23744235.2022.2027008. Epub 2022 Jan 19.

DOI:10.1080/23744235.2022.2027008
PMID:35045784
Abstract

BACKGROUND

Health care workers are at risk of acquiring SARS-CoV-2 infection. Our aim was to study the prevalence of SARS-CoV-2 nucleoprotein and spike protein specific antibodies in health care workers with occupational exposure to COVID-19 in Turku, Finland, from May to December 2020.

METHODS

Health care workers of Turku University Hospital units caring for COVID-19 patients or handling clinical SARS-CoV-2 samples were invited to participate in the study. The presence of SARS-CoV-2 nucleoprotein and spike protein specific IgG antibodies were analysed with in-house enzyme immunoassay.

RESULTS

At study enrolment, only one of the 222 (0.5%) study participants was seropositive for SARS-CoV-2 protein specific antibodies. Two additional study participants (2/222, 0.9%) seroconverted during the follow-up. All these participants were diagnosed with a RT-PCR-positive COVID-19 infection before turning seropositive.

CONCLUSION

In our study population, the prevalence of SARS-CoV-2 seropositivity remained low. The absence of seropositive cases without previous RT-PCR confirmed infections demonstrate good access to diagnostics. In addition to high vaccine coverage, high standards of infection prevention practices and use of standard personal protective equipment seem sufficient in preventing occupational SARS-CoV-2 infection in a setting with low number of circulating virus. However, it remains unclear whether similar protective practices would also be effective against more transmissible SARS-CoV-2 variants.

摘要

背景

医护人员有感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的风险。我们的目的是研究2020年5月至12月在芬兰图尔库职业暴露于新型冠状病毒肺炎(COVID-19)的医护人员中SARS-CoV-2核蛋白和刺突蛋白特异性抗体的流行情况。

方法

邀请图尔库大学医院负责护理COVID-19患者或处理临床SARS-CoV-2样本的科室的医护人员参与研究。采用内部酶免疫测定法分析SARS-CoV-2核蛋白和刺突蛋白特异性IgG抗体的存在情况。

结果

在研究入组时,222名研究参与者中只有1人(0.5%)SARS-CoV-2蛋白特异性抗体血清学呈阳性。另外两名研究参与者(2/222,0.9%)在随访期间血清转化。所有这些参与者在血清学呈阳性之前均被诊断为逆转录聚合酶链反应(RT-PCR)阳性的COVID-19感染。

结论

在我们的研究人群中,SARS-CoV-2血清学阳性的流行率仍然很低。没有先前RT-PCR确诊感染的血清学阳性病例的缺乏表明诊断途径良好。除了高疫苗接种率外,高标准的感染预防措施和使用标准个人防护设备似乎足以在循环病毒数量较少的情况下预防职业性SARS-CoV-2感染。然而,尚不清楚类似的防护措施对更具传播性的SARS-CoV-2变体是否也有效。

相似文献

1
Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study.芬兰医护人员中疫苗接种前严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清阳性率较低:一项前瞻性队列研究。
Infect Dis (Lond). 2022 Jun;54(6):448-454. doi: 10.1080/23744235.2022.2027008. Epub 2022 Jan 19.
2
SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.SARS-CoV-2 特异性中和抗体反应在 COVID-19 大流行第一波后挪威医护人员中的前瞻性队列研究。
J Infect Dis. 2021 Feb 24;223(4):589-599. doi: 10.1093/infdis/jiaa737.
3
High seroprevalence of SARS-CoV-2 antibodies in healthcare workers in COVID-19 wards indicates an occupational hazard-a prospective cohort study during the first year of the COVID-19 pandemic in Kalmar County, Sweden.在 COVID-19 病房工作的医护人员中 SARS-CoV-2 抗体的高血清阳性率表明存在职业危害——瑞典卡尔马县 COVID-19 大流行第一年的一项前瞻性队列研究。
APMIS. 2023 Sep;131(9):491-497. doi: 10.1111/apm.13343. Epub 2023 Jul 18.
4
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?核蛋白血清学阳性用于检测轻度和无症状的 SARS-CoV-2 感染:COVID-19 疫苗接种后突破感染的检测补充工具?
Vaccine. 2022 Apr 1;40(15):2251-2257. doi: 10.1016/j.vaccine.2022.03.009. Epub 2022 Mar 9.
5
The seroprevalence of SARS-CoV-2 in a rural southwest community.农村西南社区 SARS-CoV-2 的血清阳性率。
J Osteopath Med. 2021 Feb 1;121(2):199-210. doi: 10.1515/jom-2020-0287.
6
Longitudinal SARS-CoV-2 Seroprevalence among Employees in Outpatient Care Services in Hamburg.汉堡门诊护理服务员工中 SARS-CoV-2 的纵向血清流行率。
Int J Environ Res Public Health. 2023 Apr 20;20(8):5599. doi: 10.3390/ijerph20085599.
7
Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study.在接种疫苗前,比利时医院医护人员中抗 SARS-CoV-2 抗体的流行率和发生率:一项前瞻性队列研究。
BMJ Open. 2021 Jun 29;11(6):e050824. doi: 10.1136/bmjopen-2021-050824.
8
[SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].[土耳其一家大学医院医护人员中新冠病毒血清流行率:回顾性数据分析]
Mikrobiyol Bul. 2021 Apr;55(2):223-232. doi: 10.5578/mb.20219908.
9
Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.马萨诸塞州波士顿一所学术医学中心医护人员中 SARS-CoV-2 IgG 抗体的血清阳性率及相关危险因素。
Sci Rep. 2021 May 6;11(1):9694. doi: 10.1038/s41598-021-89107-5.
10
The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination.克拉科夫大学医院接种疫苗时代前医护人员中 SARS-CoV-2 抗体的血清阳性率。
Int J Environ Res Public Health. 2022 Mar 29;19(7):4044. doi: 10.3390/ijerph19074044.

引用本文的文献

1
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity.长期新冠病毒疫苗及奥密克戎感染诱导的体液免疫和细胞介导免疫。
Front Immunol. 2024 Nov 21;15:1494432. doi: 10.3389/fimmu.2024.1494432. eCollection 2024.
2
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022.2020 年 3 月至 2022 年 6 月期间芬兰 25 至 28 岁成年女性中 SARS-CoV-2 传播的血清流行病学评估。
PLoS One. 2024 Jul 11;19(7):e0305285. doi: 10.1371/journal.pone.0305285. eCollection 2024.
3
Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic.
中非共和国班吉医院工作人员中抗新冠病毒疫苗接种前后抗SARS-CoV-2抗体的血清流行率。
PLOS Glob Public Health. 2023 Nov 1;3(11):e0001497. doi: 10.1371/journal.pgph.0001497. eCollection 2023.
4
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022.2020-2022 年芬兰 SARS-CoV-2 血清流行率和人群免疫变化。
Emerg Microbes Infect. 2023 Dec;12(2):2222849. doi: 10.1080/22221751.2023.2222849.
5
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.第三剂 COVID-19 mRNA 疫苗接种后针对奥密克戎变异株的持续 T 细胞介导的免疫应答。
Front Immunol. 2023 Jan 23;14:1099246. doi: 10.3389/fimmu.2023.1099246. eCollection 2023.
6
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients.BNT162b2 信使核糖核酸(mRNA)新冠疫苗接种者和新冠康复患者的持久 T 细胞应答。
Front Immunol. 2022 Apr 22;13:869990. doi: 10.3389/fimmu.2022.869990. eCollection 2022.